BKV Corporation (NYSE:BKV - Get Free Report) traded up 5.1% on Monday . The company traded as high as $20.91 and last traded at $20.69. 572,011 shares changed hands during trading, an increase of 33% from the average session volume of 428,495 shares. The stock had previously closed at $19.68.
Analyst Ratings Changes
A number of equities research analysts have weighed in on the company. Evercore ISI lifted their price objective on BKV from $20.00 to $26.00 and gave the company an "outperform" rating in a report on Friday, May 30th. Barclays boosted their target price on BKV from $29.00 to $30.00 and gave the stock an "overweight" rating in a report on Monday, July 7th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $28.25.
Get Our Latest Stock Report on BKV
BKV Price Performance
The company has a quick ratio of 0.39, a current ratio of 0.41 and a debt-to-equity ratio of 0.13. The firm's 50-day moving average is $22.46 and its two-hundred day moving average is $21.53.
BKV (NYSE:BKV - Get Free Report) last posted its quarterly earnings data on Friday, May 9th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.26. The company had revenue of $216.13 million during the quarter, compared to the consensus estimate of $223.20 million. As a group, sell-side analysts forecast that BKV Corporation will post -1.82 EPS for the current fiscal year.
Insider Activity at BKV
In other BKV news, insider Eric S. Jacobsen sold 31,350 shares of the company's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $22.02, for a total transaction of $690,327.00. Following the completion of the sale, the insider owned 257,903 shares in the company, valued at approximately $5,679,024.06. The trade was a 10.84% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO David Tameron sold 4,409 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $17.94, for a total transaction of $79,097.46. Following the completion of the transaction, the chief financial officer directly owned 43,370 shares of the company's stock, valued at $778,057.80. This trade represents a 9.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 217,208 shares of company stock worth $4,695,833. Company insiders own 4.11% of the company's stock.
Hedge Funds Weigh In On BKV
A number of large investors have recently added to or reduced their stakes in the company. Driehaus Capital Management LLC bought a new stake in shares of BKV in the 4th quarter valued at about $9,553,000. Geode Capital Management LLC acquired a new stake in shares of BKV during the 4th quarter worth approximately $7,728,000. Quantbot Technologies LP acquired a new stake in shares of BKV during the 1st quarter worth approximately $1,605,000. Corebridge Financial Inc. acquired a new stake in BKV in the fourth quarter valued at approximately $170,000. Finally, Bank of New York Mellon Corp boosted its position in BKV by 21.2% in the first quarter. Bank of New York Mellon Corp now owns 35,453 shares of the company's stock valued at $745,000 after buying an additional 6,209 shares in the last quarter.
BKV Company Profile
(
Get Free Report)
BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BKV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.
While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.